{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:58:27Z","timestamp":1781326707272,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/T017759\/1"],"award-info":[{"award-number":["BB\/T017759\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/X019756\/1"],"award-info":[{"award-number":["BB\/X019756\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/R513209\/1"],"award-info":[{"award-number":["EP\/R513209\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8618\/A27574"],"award-info":[{"award-number":["C8618\/A27574"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118413","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:45:55Z","timestamp":1764315955000},"page":"118413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["New mechanistic insights into targeted protein degradation using Raman-active theranostic hydrophobic tags"],"prefix":"10.1016","volume":"303","author":[{"given":"Craig F.","family":"Steven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa Punaha","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata N.","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Lochhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poppy","family":"Winlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex von","family":"Kriegsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.J.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-8794","authenticated-orcid":false,"given":"Valerie G.","family":"Brunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4619-1506","authenticated-orcid":false,"given":"Alison N.","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118413_bib1","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112635","article-title":"Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation","volume":"204","author":"Go","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib3","article-title":"Discovery of norbornene as a novel hydrophobic tag applied in protein degradation","volume":"62","author":"Xie","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118413_bib4a","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.597","article-title":"Small-Molecule Hydrophobic Tagging-Induced Degradation of HaloTag Fusion Proteins","volume":"7","author":"Neklesa","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118413_bib4b","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41589-019-0421-4","article-title":"Discovery of a first-in-class EZH2 selective degrader","volume":"16","author":"Ma","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118413_bib4c","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/acsmedchemlett.1c00500","article-title":"Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties","volume":"13","author":"Hirai","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118413_bib4d","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1021\/acs.jmedchem.2c02045","article-title":"Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib4e","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1021\/acs.jmedchem.4c02129","article-title":"Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy","volume":"68","author":"Qiu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib4f","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/acsomega.4c09726","article-title":"Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions","volume":"10","author":"Balestrero","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118413_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202300953","article-title":"Stretching the bisalkyne Raman spectral palette reveals a new electrophilic covalent motif","volume":"29","author":"Ravindra","year":"2023","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.118413_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202200393","article-title":"Design, synthesis, and analytical evaluation of Fsp3 \u2010inspired Raman probes for cellular imaging","author":"Steven","year":"2022","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib7a","series-title":"Stimulated Raman Scattering Microscopy: Techniques and Applications","first-page":"403","article-title":"Use of SRS microscopy for imaging drugs","author":"Steven","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118413_bib7b","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acs.analchem.4c01413","article-title":"Innovative Approaches for Drug Discovery: Quantifying Drug Distribution and Response with Raman Imaging","volume":"96","author":"Dunnington","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib8","doi-asserted-by":"crossref","first-page":"20681","DOI":"10.1021\/ja308529n","article-title":"Alkyne-tag Raman imaging for visualization of mobile small molecules in live cells","volume":"134","author":"Yamakoshi","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118413_bib9","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1021\/acs.jmedchem.9b01546","article-title":"Utilizing stimulated Raman scattering microscopy to study intracellular distribution of label-free ponatinib in live cells","volume":"63","author":"Sepp","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/acs.analchem.3c04242","article-title":"Facilitated transport of EGFR inhibitors plays an important role in their cellular uptake","volume":"96","author":"Wong","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib11","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1021\/acs.analchem.3c05946","article-title":"Visualization of modified bisarylbutadiyne-tagged small molecules in live-cell nuclei by stimulated Raman scattering microscopy","volume":"96","author":"Kawaguchi","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib12a","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.1021\/acs.jmedchem.2c01243","article-title":"Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT","volume":"65","author":"Cheng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib12b","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116184","article-title":"Fluorescence theranostic PROTACs for real-time visualization of ER\u03b1 degradation","volume":"267","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib12c","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.143883","article-title":"Tailoring albumin-based theranostic PROTACs nanoparticles for enhanced NIR-II bioimaging and synergistic cancer chemo-phototherapy","volume":"469","author":"Hu","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejmech.2025.118413_bib13","series-title":"Proc. SPIE 12357, Visualizing and Quantifying Drug Distribution in Tissue VII","article-title":"Application of stimulated Raman scattering (SRS) microscopy for evaluation of olaparib biodistribution in an ovarian cancer cell line","author":"Steven","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118413_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/cancers14061420","article-title":"PARP inhibitors resistance: mechanisms and perspectives","volume":"14","author":"Giudice","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118413_bib15a","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nmeth.4578","article-title":"Supermultiplexed optical imaging and barcoding with engineered polyynes","volume":"15","author":"Hu","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2025.118413_bib15b","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s43586-025-00389-9","article-title":"Alkyne-tag Raman imaging and sensing of bioactive compounds","volume":"5","author":"Dodo","year":"2025","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.ejmech.2025.118413_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-13-0801","article-title":"Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors","volume":"13","author":"Thurber","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118413_bib17","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1021\/acschembio.6b00346","article-title":"A modular probe strategy for drug localization, target identification and target occupancy measurement on single cell level","volume":"11","author":"Rutkowska","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118413_bib18a","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/1087057114538319","article-title":"Insights into PARP Inhibitors' Selectivity Using Fluorescence Polarization and Surface Plasmon Resonance Binding Assays","volume":"19","author":"Papeo","year":"2014","journal-title":"SLAS Discov."},{"key":"10.1016\/j.ejmech.2025.118413_bib18b","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/acs.biochem.3c00243","article-title":"Slow Dissociation from the PARP1\u2013HPF1 Complex Drives Inhibitor Potency","volume":"62","author":"Stojanovic","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118413_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/1541-7786.MCR-15-0191-T","article-title":"Mechanistic dissection of PARP1 trapping and the impact on in vivo tolerability and efficacy of PARP inhibitors","volume":"13","author":"Hopkins","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118413_bib20","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1002\/anie.201304096","article-title":"Bioorthogonal approach to identify unsuspected drug targets in live cells","volume":"52","author":"Yang","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118413_bib21","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s00259-023-06249-6","article-title":"PET imaging of PARP expression using 68Ga-labelled inhibitors","volume":"50","author":"Wang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118413_bib22","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016573","article-title":"Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1","volume":"296","author":"Ryan","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq0414","article-title":"A two-step mechanism governing PARP1-DNA retention by PARP inhibitors","volume":"8","author":"Xue","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118413_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","article-title":"PARP-1 activation requires local unfolding of an autoinhibitory domain","volume":"60","author":"Dawicki-McKenna","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118413_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanh\u00e4usser","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118413_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41589-019-0379-2","article-title":"Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118413_bib27","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1021\/acs.jmedchem.0c00821","article-title":"Discovery of SK-575 as a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for treating cancers","volume":"63","author":"Cao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib28","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.3390\/ijms22126407","article-title":"Hydrophobic tagging-mediated degradation of transcription coactivator SRC-1","volume":"22","author":"Choi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118413_bib29","doi-asserted-by":"crossref","first-page":"11615","DOI":"10.1021\/acs.jmedchem.0c00793","article-title":"Understanding the metabolism of proteolysis targeting Chimeras (PROTACs): the next step toward pharmaceutical applications","volume":"63","author":"Goracci","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1541-7786.MCR-17-0607","article-title":"Olaparib-induced adaptive response is disrupted by FOXM1 targeting that enhances sensitivity to PARP inhibition","volume":"16","author":"Fang","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118413_bib31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neo.2014.05.005","article-title":"PARPi-FL - a fluorescent PARP1 inhibitor for glioblastoma imaging","volume":"16","author":"Irwin","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2025.118413_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41392-020-00358-6","article-title":"Development of synthetic lethality in cancer: molecular and cellular classification","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.118413_bib33a","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/acsmedchemlett.0c00627","article-title":"Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging Molecules","volume":"12","author":"Li","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118413_bib33b","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.853993","article-title":"LPM3770277, a Potent Novel CDK4\/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118413_bib34","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acsmedchemlett.4c00274","article-title":"Identification of Boc2Lys-Linked ethacrynic acid and its analogues as efficient glutathione S-Transferase degraders","volume":"15","author":"Sun","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118413_bib35","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1074\/jbc.REV118.002804","article-title":"The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: getting by with a little help from ERdj friends","volume":"294","author":"Pobre","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib36","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1021\/acs.jmedchem.4c00131","article-title":"Novel acyl thiourea-based hydrophobic tagging degraders exert potent anti-influenza activity through two distinct endonuclease polymerase acidic-targeted degradation pathways","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115741","article-title":"Hydrophobic tag-based protein degradation: development, opportunity and challenge","volume":"260","author":"He","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2741\/A291","article-title":"Role of E2F in cell cycle control and cancer","volume":"3","author":"Johnson","year":"1998","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2025.118413_bib39a","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1038\/sj.onc.1206897","article-title":"PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase","volume":"22","author":"Simbulan-Rosenthal","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118413_bib39b","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/cancers12102907","article-title":"PARP1 Deficiency Reduces Tumour Growth by Decreasing E2F1 Hyperactivation: A Novel Mechanism in the Treatment of Cancer","volume":"12","author":"Iglesias","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118413_bib40","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.3390\/ijms24108849","article-title":"A new opportunity for \u201cOld\u201d molecules: targeting PARP1 activity through a non-enzymatic mechanism","volume":"24","author":"Iglesias","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118413_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/cdd.2014.146","article-title":"Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation","volume":"22","author":"Kumari","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118413_bib42","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1080\/15384101.2015.1085137","article-title":"Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation","volume":"14","author":"Rein","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2025.118413_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107985","article-title":"The ubiquitin ligase TRIP12 limits PARP1 trapping and constrains PARP inhibitor efficiency","volume":"32","author":"Gatti","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118413_bib44a","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1039\/D0AN01972K","article-title":"Recent advances in the use of stimulated Raman scattering in histopathology","volume":"146","author":"Lee","year":"2021","journal-title":"Analyst"},{"key":"10.1016\/j.ejmech.2025.118413_bib44b","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.1165758","article-title":"Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman Scattering Microscopy","volume":"322","author":"Freudiger","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118413_bib45a","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1080\/14756366.2020.1804382","article-title":"Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)","volume":"35","author":"Zhang","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib45b","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1021\/acs.jmedchem.0c00821","article-title":"Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers","volume":"63","author":"Cao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118413_bib45c","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41419-024-07277-2","article-title":"Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342501178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:46:11Z","timestamp":1781325971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342501178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":60,"alternative-id":["S022352342501178X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118413","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New mechanistic insights into targeted protein degradation using Raman-active theranostic hydrophobic tags","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118413"}}